Morbidity and Mortality Reduction Associated with the Use of Erythropoietin

Publisher： Karger

E-ISSN： 2235-3186|85|1|2-8

ISSN： 1660-8151

Source： Nephron, Vol.85, Iss.1, 2000-04, pp. : 2-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Morbidity and Mortality on Maintenance Haemodialysis

By  

Nephron, Vol. 80, Iss. 4, 1998-12 ,pp. : 380-400

Karger

Access to resources Recommend Favorite

Higher Doses of Erythropoietin-Stimulating Agents and Hyporesponsiveness to Their Effects Are Associated with Increased Mortality among Prevalent Hemodialysis Patients

By  

Blood Purification, Vol. 36, Iss. 1, 2013-05 ,pp. : 29-36

Karger

Access to resources Recommend Favorite

Risk Factors Associated with Cardiovascular Morbidity and Mortality in Spanish Incident Hemodialysis Patients: Two-Year Results from the ANSWER Study

By  

Blood Purification, Vol. 33, Iss. 1-3, 2011-11 ,pp. : 21-29

Karger

Access to resources Recommend Favorite

Use of Calcium Channel Blockers is Associated with Mortality in Patients with Chronic Kidney Disease

By  

Kidney and Blood Pressure Research, Vol. 40, Iss. 6, 2015-0 ,pp. : 630-637

Karger

Access to resources Recommend Favorite

Incidence of Infectious Morbidity and Mortality in Dialysis Patients

By  

Blood Purification, Vol. 20, Iss. 5, 2002-08 ,pp. : 477-480

Karger

Access to resources Recommend Favorite